262 related articles for article (PubMed ID: 7886572)
1. Plasmapheresis for the preparation of HIV free cryoprecipitate.
Tardtong P; Chuansumrit A; Stabanswadigan S; Chiewsilp P; Isarangkura P
Southeast Asian J Trop Med Public Health; 1993; 24 Suppl 1():195-7. PubMed ID: 7886572
[TBL] [Abstract][Full Text] [Related]
2. Plasma and plasma derivatives in therapeutic plasmapheresis.
McLeod BC
Transfusion; 2012 May; 52 Suppl 1():38S-44S. PubMed ID: 22578370
[TBL] [Abstract][Full Text] [Related]
3. The safe blood components for a hemophilia patient: a case report.
Chuansumrit A; Pandhawong S; Tardtong P; Isarangkura P
Southeast Asian J Trop Med Public Health; 1993; 24 Suppl 1():198-200. PubMed ID: 7886573
[TBL] [Abstract][Full Text] [Related]
4. Plasma exchange donation of cryoprecipitate after DDAVP stimulation: an alternative source of factor VIII.
McLeod BC; Scott JP
Prog Clin Biol Res; 1990; 324():189-98. PubMed ID: 2106687
[TBL] [Abstract][Full Text] [Related]
5. Unconventional diagnosis of Normandy-type von Willebrand's disease in a blood donor.
Kashyap S; Nesbitt IM; Makris M
Transfus Med; 2004 Apr; 14(2):181-4. PubMed ID: 15113383
[TBL] [Abstract][Full Text] [Related]
6. A minipool process for solvent-detergent treatment of cryoprecipitate at blood centres using a disposable bag system.
Burnouf T; Goubran HA; Radosevich M; Sayed MA; Gorgy G; El-Ekiaby M
Vox Sang; 2006 Jul; 91(1):56-62. PubMed ID: 16756602
[TBL] [Abstract][Full Text] [Related]
7. Comparison of coagulation factor XIII content and concentration in cryoprecipitate and fresh-frozen plasma.
Caudill JS; Nichols WL; Plumhoff EA; Schulte SL; Winters JL; Gastineau DA; Rodriguez V
Transfusion; 2009 Apr; 49(4):765-70. PubMed ID: 19192257
[TBL] [Abstract][Full Text] [Related]
8. The impact of different intensities of regular donor plasmapheresis on humoral and cellular immunity, red cell and iron metabolism, and cardiovascular risk markers.
Tran-Mi B; Storch H; Seidel K; Schulzki T; Haubelt H; Anders C; Nagel D; Siegler KE; Vogt A; Seiler D; Hellstern P
Vox Sang; 2004 Apr; 86(3):189-97. PubMed ID: 15078254
[TBL] [Abstract][Full Text] [Related]
9. A prospective trial on the safety of long-term intensive plasmapheresis in donors.
Bechtloff S; Tran-My B; Haubelt H; Stelzer G; Anders C; Hellstern P
Vox Sang; 2005 Apr; 88(3):189-95. PubMed ID: 15787729
[TBL] [Abstract][Full Text] [Related]
10. [A new separation protocol (DRBCP-F) for automated blood component donation with the MCS 3p cell separator for collection of leukocyte depleted erythrocyte concentrates and plasma].
Zeiler T; Kretschmer V
Beitr Infusionsther Transfusionsmed; 1997; 34():118-22. PubMed ID: 9417335
[TBL] [Abstract][Full Text] [Related]
11. Factor VIII, factor IX and fibrinogen content in cryoprecipitate, fresh plasma and cryoprecipitate-removed plasma.
Bejrachandra S; Chandanayingyong D; Visudhiphan S; Tumliang S; Kaewkamol K; Siribunrit U
Southeast Asian J Trop Med Public Health; 1993; 24 Suppl 1():162-4. PubMed ID: 7886562
[TBL] [Abstract][Full Text] [Related]
12. Serum IgG and IgM levels in new and regular long-term plasmapheresis donors.
Burgin M; Hopkins G; Moore B; Nasser J; Richardson A; Minchinton R
Med Lab Sci; 1992 Dec; 49(4):265-70. PubMed ID: 1339930
[TBL] [Abstract][Full Text] [Related]
13. A prospective multicentre study on the safety of long-term intensive plasmapheresis in donors (SIPLA).
Schulzki T; Seidel K; Storch H; Karges H; Kiessig S; Schneider S; Taborski U; Wolter K; Steppat D; Behm E; Zeisner M; Hellstern P;
Vox Sang; 2006 Aug; 91(2):162-73. PubMed ID: 16907878
[TBL] [Abstract][Full Text] [Related]
14. Haemostasis with cryoprecipitate in patients undergoing surgery for severe von Willebrand disease.
Mathews V; Srivastava A; Nair SC; Chandy M
Natl Med J India; 2000; 13(4):188-90. PubMed ID: 11002685
[TBL] [Abstract][Full Text] [Related]
15. Effect of cryoprecipitate and plasma on plasma von Willebrand factor multimeters and bleeding time in Doberman Pinschers with type-I von Willebrand's disease.
Ching YN; Meyers KM; Brassard JA; Wardrop KJ
Am J Vet Res; 1994 Jan; 55(1):102-10. PubMed ID: 8141483
[TBL] [Abstract][Full Text] [Related]
16. [Factor VIII:C activity during heat inactivation of viruses in cryoprecipitates].
Grgicević D; Flego I; Marchiotti I; Lupret L; Rajninger-Miholić M
Lijec Vjesn; 1990; 112(7-8):212-5. PubMed ID: 2127297
[TBL] [Abstract][Full Text] [Related]
17. HIV seroconversion in Thai hemophiliacs up to 1991.
Isarangkura P; Chuansumrit A; Hathirat P; Panthangkura W; Mahaphan W; Limsuwan A; Chiewsilp P
Southeast Asian J Trop Med Public Health; 1993; 24 Suppl 1():191-4. PubMed ID: 7886571
[TBL] [Abstract][Full Text] [Related]
18. [Estimation of the blood donation necessary for self-sufficiency of blood products].
Pinto V; Hernández Mejía R; Cueto A
Sangre (Barc); 1999 Feb; 44(1):38-43. PubMed ID: 10323095
[TBL] [Abstract][Full Text] [Related]
19. Cryoprecipitate prepared from plasma frozen within 24 hours after phlebotomy contains acceptable levels of fibrinogen and VIIIC.
Yazer MH; Triulzi DJ; Hassett AC; Kiss JE
Transfusion; 2010 May; 50(5):1014-8. PubMed ID: 20003046
[TBL] [Abstract][Full Text] [Related]
20. Hepatitis C virus transmission through quarantine fresh-frozen plasma.
Humpe A; Legler TJ; Nübling CM; Riggert J; Unger G; Wolf C; Heermann KH; Köhler M
Thromb Haemost; 2000 Nov; 84(5):784-8. PubMed ID: 11127856
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
